Referencias bibliográficas

  1. Elison, E., Vigsnaes, L. K., Rindom Krogsgaard, L., Rasmussen, J., Sørensen, N., McConnell, B., Hennet, T., Sommer, M. O., & Bytzer, P. (2016). Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. The British journal of nutrition, 116(8), 1356–1368. https://doi.org/10.1017/S0007114516003354
  2. Arboleya, S.,Watkins, C., Stanton, C., & Ross, R. P. (2016). Gut Bifidobacteria Populations in Human Health and Aging. Frontiers In Microbiology, 7.
  3. Derrien, M., Turroni, F., Ventura, M., & Van Sinderen, D. (2022). Insights into endogenous Bifidobacterium species in the human gut microbiota during
  4. Eskesen, D., Jespersen, L., Michelsen, B., Whorwell, P. J., Müller-Lissner,S., & Morberg, C. M. (2015). Effect of the probiotic strain Bifidobacterium animalis subsp.lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind,placebo-controlled, parallel-group trial. British Journal Of Nutrition, 114(10), 1638-1646
  5. Kumar H, Collado MC, Wopereis H, Salminen S, Knol J, Roeselers G. The Bifidogenic Effect Revisited—Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life. Microorganisms. 2020; 8(12):1855. https://doi.org/10.3390/microorganisms8121855
  6. Šuligoj T, Vigsnæs LK, Abbeele PVD, et al. Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function. Nutrients. 2020;12(9):2808. Published 2020 Sep 13. doi:10.3390/nu12092808
  7. Jacobs, J. P., Lee, M. L., Rechtman, D. J., Sun, A. K., Autran, C., & Niklas, V. (2023). Human milk oligosaccharides modulate the intestinal microbiome of healthy adults. Scientific reports, 13(1), 14308. https://doi.org/10.1038/s41598-023-41040-5.
  8. Sanz Morales, P., Wijeyesekera, A., Robertson, M. D., Jackson, P. P. J., & Gibson, G. R. (2022). The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome. Microorganisms, 10(12), 2338. https://doi.org/10.3390/microorganisms10122338
  9. Bajic D, Wiens F, Wintergerst E, Deyaert S, Baudot A, Abbeele PVd. HMOs Impact the Gut Microbiome of Children and Adults Starting from Low Predicted Daily Doses. Metabolites. 2024; 14(4):239. https://doi.org/10.3390/metabo14040239
  10. Dedon LR, Özcan E, Rani A, Sela DA. Bifidobacterium infantis Metabolizes 2’Fucosyllactose-Derived and Free Fucose Through a Common Catabolic Pathway Resulting in 1,2-Propanediol Secretion. Front Nutr. 2020;7:583397. Published 2020 Nov 24. doi:10.3389/fnut.2020.583397
  11. Ehrlich, A. M., Pacheco, A. R., Henrick, B. M., Taft, D., Xu, G., Huda, M. N., Mishchuk, D., Goodson, M. L., Slupsky, C., Barile, D., Lebrilla, C. B., Stephensen, C. B., Mills, D. A., & Raybould, H. E. (2020). Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC microbiology, 20(1), 357. https://doi.org/10.1186/s12866-020-02023-y
  12. Button, J. E., Cosetta, C. M., Reens, A. L., Brooker, S. L., Rowan-Nash, A. D., Lavin, R. C., Saur, R., Zheng, S., Autran, C. A., Lee, M. L., Sun, A. K., Alousi, A. M., Peterson, C. B., Koh, A. Y., Rechtman, D. J., Jenq, R. R., & McKenzie, G. J. (2023). Precision modulation of dysbiotic adult microbiomes with a human-milk-derived synbiotic reshapes gut microbial composition and metabolites. Cell Host & Microbe, 31(9), 1523-1538.e10.
  13. Button, J. E., Autran, C. A., Reens, A. L., Cosetta, C. M., Smriga, S., Ericson, M., Pierce, J. V., Cook, D. N., Lee, M. L., Sun, A. K., Alousi, A. M., Koh, A. Y., Rechtman, D. J., Jenq, R. R., & McKenzie, G. J. (2022). Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics. Cell host & microbe, 30(5), 712–725.e7. https://doi.org/10.1016/j.chom.2022.04.001
  14. Andermann, T. M., & Bhatt, A. P. (2022). The mother of all synbiotics: Just a spoonful of sugar makes the bugs stick around. Cell host & microbe, 30(5), 601–603. https://doi.org/10.1016/j.chom.2022.04.010
  15. Pitkala, K. H., Strandberg, T. E., Finne Soveri, U. H., Ouwehand, A. C., Poussa, T., & Salminen, S. (2007). Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. The journal of nutrition, health & aging, 11(4), 305–311.
  16. Fredua-Agyeman, M., Stapleton, P., Basit, A. W., Beezer, A. E., & Gaisford, S. (2017). In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study. International journal of pharmaceutics, 517(1-2), 96–103. https://doi.org/10.1016/j.ijpharm.2016.12.005
  17. Krumbeck, J. A., Rasmussen, H. E., Hutkins, R. W., Clarke, J., Shawron, K., Keshavarzian, A., & Walter, J. (2018). Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome, 6(1), 121. https://doi.org/10.1186/s40168-018-0494-4
  18. Schalich, K. M., Buendia, M. A., Kaur, H., Choksi, Y. A., Washington, M. K., Codreanu, G. S., Sherrod, S. D., McLean, J. A., Peek, R. M., Jr, Acra, S. A., Townsend, S. D., & Yan, F. (2024). A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism. mBio, 15(4), e0029824. https://doi.org/10.1128/mbio.00298-24